Nikon to use Lonza know-how to get into gene contract work; Pfizer India plant beset by labor issues;

> Lonza and Nikon have worked a deal for Nikon to use Lonza's expertise and technology to set up its own cell and gene therapy contract manufacturing business. Release

> OPKO Health is getting an FDA- and EMA-approved high-containment research and development, and manufacturing facility in Waterford, Ireland with its acquisition of EirGen. Release

> China's National Health and Family Planning Commission is now requiring detailed records on the supply and storage of vaccines, including the temperatures during their distribution and storage. Story

> Production at a Pfizer ($PFE) plant in Goa, India has reportedly been affected by a labor dispute. aReport

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.